PDW

Platelet Distribution Width

Complete Blood Count

What is Platelet Distribution Width?

Platelet distribution width (PDW) measures the variation in platelet size in your blood sample, analogous to how RDW measures variation in red blood cell size. It is expressed as a percentage or in femtoliters (depending on the analyzer) and reflects the heterogeneity of the circulating platelet population. A low PDW means platelets are uniform in size, while a high PDW indicates a wide range of platelet sizes—from small, aged platelets to large, young, newly released platelets and possibly giant platelets.

PDW is calculated from the platelet volume distribution curve generated by automated hematology analyzers and is reported alongside the platelet count and MPV. Under normal conditions, megakaryocytes in the bone marrow release platelets of relatively consistent size, producing a narrow distribution. When the bone marrow is stimulated to increase platelet production—such as in response to peripheral destruction or consumption—it releases a greater proportion of large, immature platelets, widening the distribution. Conversely, bone marrow suppression may produce uniformly small platelets with a narrow PDW. Clinical interest in PDW has grown alongside MPV, as it adds another dimension to platelet analysis.

Why It Matters

PDW complements the platelet count and MPV by providing information about platelet size variability. A high PDW combined with a high MPV and low platelet count strongly suggests active platelet destruction with compensatory bone marrow response, as seen in immune thrombocytopenia (ITP). This pattern helps distinguish destructive causes from bone marrow failure, where PDW tends to be normal or low. PDW has also shown promise as an inflammatory and prognostic marker—elevated PDW has been associated with sepsis, acute coronary syndromes, preeclampsia, and various cancers. Like MPV, PDW provides additional diagnostic information that is essentially free because it is already measured by the hematology analyzer.

Normal Reference Ranges

GroupRangeUnit
Adults9–17%
Adults (alternative scale)8.3–56.6fL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High PDW Levels Mean

Common Causes

  • Immune thrombocytopenic purpura (ITP)
  • Myeloproliferative disorders (essential thrombocythemia)
  • Sepsis and disseminated intravascular coagulation
  • Megaloblastic anemia (B12 or folate deficiency)
  • Acute coronary syndromes

Possible Symptoms

  • Bruising and bleeding (if platelet count is low)
  • Petechiae or purpura
  • Symptoms related to the underlying condition
  • May be asymptomatic when platelet count is normal

What to do: Elevated PDW should be interpreted alongside platelet count and MPV. If platelet count is low with high PDW and MPV, consider destructive thrombocytopenias and evaluate with a peripheral blood smear, anti-platelet antibodies, and possibly bone marrow biopsy. In the setting of sepsis, check coagulation parameters (PT, aPTT, D-dimer, fibrinogen). If PDW is elevated with a normal or high platelet count, myeloproliferative disorders should be considered with JAK2 mutation testing and hematology referral.

What Low PDW Levels Mean

Common Causes

  • Bone marrow suppression (chemotherapy, radiation)
  • Aplastic anemia
  • Hypersplenism with uniform platelet sequestration
  • Normal variation—uniform platelet production

Possible Symptoms

  • Symptoms of underlying bone marrow condition if present
  • Low PDW alone is typically not clinically significant
  • Bleeding symptoms if associated with low platelet count

What to do: Low PDW in isolation is rarely a clinical concern. If accompanied by low platelet count and low MPV, it suggests impaired bone marrow production and may warrant bone marrow evaluation. Review medications for bone marrow suppressants. If all platelet indices are normal, no specific follow-up for PDW alone is needed. Ensure the sample was analyzed promptly, as delayed analysis in EDTA can affect platelet indices.

When Is PDW Testing Recommended?

  • As part of a routine CBC (automatically reported by most modern analyzers)
  • When evaluating the cause of thrombocytopenia alongside MPV
  • When investigating myeloproliferative neoplasms
  • When assessing inflammatory or septic states

Frequently Asked Questions

PDW and RDW measure the same concept—size variability—but for different blood cell types. RDW measures variation in red blood cell size (anisocytosis), while PDW measures variation in platelet size. Both are derived from the volume distribution curve of their respective cell populations. RDW is widely used in anemia classification (e.g., distinguishing iron deficiency from thalassemia). PDW is used alongside MPV to evaluate platelet production and destruction. Both elevated RDW and elevated PDW have been linked to inflammation and poor clinical outcomes, suggesting that increased cell size variability is a general marker of physiological stress affecting the bone marrow.
PDW has limitations that affect its clinical reliability. First, PDW values are not standardized across different hematology analyzers—each manufacturer uses slightly different algorithms and reporting scales (percentage vs. femtoliters), making cross-laboratory comparisons difficult. Second, PDW is sensitive to pre-analytical variables: delayed sample analysis, temperature changes, and platelet clumping can all alter PDW values. Third, reference ranges vary by laboratory. Despite these limitations, PDW shows consistent patterns in research—elevated PDW in ITP vs. normal in aplastic anemia, and elevated PDW as an inflammatory marker. It is most useful when tracked longitudinally within the same laboratory rather than as a standalone diagnostic value.
Several studies have found that elevated PDW in early-to-mid pregnancy may be an early marker of developing preeclampsia. In preeclampsia, endothelial dysfunction and placental factors cause increased platelet activation and consumption, triggering compensatory production of larger, younger platelets and widening the distribution. One systematic review found that PDW was significantly higher in women who developed preeclampsia compared to those with normal pregnancies, with changes detectable before clinical symptoms. However, PDW alone is not sensitive or specific enough for clinical screening—it is best used as part of a panel including platelet count, MPV, and other biomarkers (sFlt-1/PlGF ratio) for preeclampsia risk assessment.

Related Biomarkers

PLTPlateletsMPVMean Platelet VolumePCTPlateletcritRDWRed Cell Distribution Width

Want your PDW levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.